Pages that link to "Q37429034"
Jump to navigation
Jump to search
The following pages link to Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study (Q37429034):
Displaying 7 items.
- Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings (Q38895754) (← links)
- Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer (Q42371820) (← links)
- Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials (Q45848384) (← links)
- Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting report (Q51409558) (← links)
- A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer (Q56516705) (← links)
- Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment (Q96031129) (← links)
- Angiogenesis in endometrial carcinoma: Therapies and biomarkers, current options, and future perspectives (Q104615269) (← links)